alexa

GET THE APP

Surya Ayalasomayajula | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 312

Clinical Pharmacology & Biopharmaceutics received 312 citations as per google scholar report

Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Surya Ayalasomayajula

Surya Ayalasomayajula Senior Investigator II at Novartis Pharamceuticals Co.
Greater New York City Area, USA

Biography

Surya Ayalasomayajula is working as Senior Investigator II at Novartis Pharamceuticals Co.USA. Lead PK group efforts in submitting IND and NDA applications. Contributed to ClinPharm summary, Clin biopharm summary, Clin Overview, CSE, CSS, RMP, Company core data sheet, Prescription information and other key NDA documents.  Plan, design, analyze, interpret, and report data from clinical pharmacokinetics (PK) and PK/Pharmacodynamic (PD) studies Responsible for the PK, and PK/PD components of the stud protocols, reports, and drug development plans. Serve as the key contact for all PK, and PK/PD related issues pertinent to the development of drug candidate. Interact with multiple line functions to ensure preclinical and clinical pharmacokinetic/pharmacodynamic information is used optimally for the early and late phase clinical development plans.

Research Interest

Pharmacokinetics, DMPK, Drug Metabolism, Bioanalysis, Clinical Development, Drug Development, HPLC, Clinical Pharmacology, PK/PD, Biopharmaceuticals

Publications

Global Speakers in the subject

Global Experts in the subject

Top